Early data from Lexeo’s gene therapy for rare heart disease shows promise
Lexeo said Monday that a gene therapy targeting cardiac complications of Friedrich’s ataxia reduced signs of heart disease.
Related Articles
There’s now a chance for bipartisan health care policies, but partisan tensions are running high
A lot stands in the way of bipartisan health care policymaking, threatening PBM reform and extenders.
Use of antibiotic to reduce STIs appears to be fueling some antibiotic resistance, research shows
The use of the antibiotic doxycycline to reduce STIs appears to be fueling some antibiotic resistance, according to new research.
FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy
The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment continues.
Academic groups finalize counterproposal to Trump’s research overhead cuts
A coalition of academic organizations has finalized a proposed alternative to the Trump administration’s plan to cut billions of dollars in research
Ending the federal LGBTQ+ suicide prevention line is a public health failure
Ending the federal LGBTQ+ suicide prevention line is a public health failure, write two leaders in prevention and crisis response.
Trump administration cuts undocumented immigrants’ access to range of federally funded programs
HHS will limit immigrants’ access to more federally funded programs, like health clinics and head start.
Will future med students like me get the same chances I did?
Future doctors from underserved communities will have a harder time paying for med school under the new federal loan caps, one student writes.
California stem cell agency shutting down unique human tissue biobank
The California Institute for Regenerative Medicine and its partners are selling thousands of stem cell samples before many of them are discarded.
Trump administration cuts undocumented immigrants’ access to range of federally funded programs
HHS will limit immigrants’ access to more federally funded programs, like health clinics and head start.
Bionic knee developed by MIT researchers gives amputees a new world of motion
A bionic knee developed by Massachusetts Institute of Technology researchers is giving amputees a new world of motion.